We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+8.56%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+596.65%
AUM
$821B
AUM Growth
+$62.3B
Cap. Flow
+$23.5B
Cap. Flow %
2.87%
Top 10 Hldgs %
16.79%
Holding
7,579
New
751
Increased
3,314
Reduced
2,056
Closed
652
Avg Time Held Equity + Options
17.5 quarters
Top 10 Avg Time Held Equity + Options
16.2 quarters
Top 20 Avg Time Held Equity + Options
12.2 quarters
Avg Time Held Equity only
18.8 quarters
Top 10 Avg Time Held Equity only
16.2 quarters
Top 20 Avg Time Held Equity only
14.4 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.28%
2 Technology 17.17%
3 Healthcare 10.79%
4 Financials 9.36%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DVLT
6301
Datavault AI
DVLT
$146M
$1K ﹤0.01%
+4
New +$3.91K
2023 Q1
0 quarters
DGXX
6302
Digi Power X Inc
DGXX
$389M
$1K ﹤0.01%
132
– –
2022 Q2
3 quarters
ACHL
6303
DELISTED
Achilles Therapeutics
ACHL
$1K ﹤0.01%
989
– –
2021 Q4
5 quarters
HYB
6304
DELISTED
New America High Income Fund, Inc.
HYB
$1K ﹤0.01%
+83
New +$565
2023 Q1
0 quarters
VIRX
6305
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1K ﹤0.01%
721
– –
2021 Q2
7 quarters
INSI
6306
DELISTED
Insight Select Income Fund
INSI
$1K ﹤0.01%
+36
New +$568
2023 Q1
0 quarters
USAP
6307
DELISTED
Universal Stainless & Alloy
USAP
$1K ﹤0.01%
157
-192
-55% -$1.61K
2022 Q1
4 quarters
FAIL
6308
DELISTED
Cambria Global Tail Risk ETF
FAIL
$1K ﹤0.01%
+44
New +$871
2023 Q1
0 quarters
IVCPW
6309
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
– –
0
– –
2022 Q2
3 quarters
EXAI
6310
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$1K ﹤0.01%
+96
New +$651
2023 Q1
0 quarters
TDW.WS
6311
DELISTED
Tidewater Inc.
TDW.WS
– –
0
– –
2022 Q4
1 quarter
LKCO
6312
DELISTED
Luokung Technology Corp Ordinary Shares
LKCO
$1K ﹤0.01%
+89
New +$3.23K
2023 Q1
0 quarters
LCW.WS
6313
DELISTED
Learn CW Investment Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
LCW.WS
– –
0
– –
2022 Q2
3 quarters
CVIIW
6314
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
– –
0
– –
2023 Q1
0 quarters
CNTG
6315
DELISTED
Centogene N.V. Common Shares
CNTG
$1K ﹤0.01%
871
– –
2019 Q4
13 quarters
CALB
6316
DELISTED
California BanCorp Common Stock
CALB
$1K ﹤0.01%
68
+67
+6,700% +$1.58K
2022 Q3
2 quarters
CYT
6317
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$1K ﹤0.01%
496
– –
2021 Q3
6 quarters
BPTH
6318
DELISTED
Bio-Path Holdings Inc
BPTH
$1K ﹤0.01%
+23
New +$828
2023 Q1
0 quarters
ALYA
6319
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$1K ﹤0.01%
400
-1,500
-79% -$2.73K
2021 Q2
7 quarters
IBDO
6320
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$1K ﹤0.01%
35
– –
2020 Q3
10 quarters
TBCPW
6321
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
– –
0
– –
2023 Q1
0 quarters
HWELU
6322
DELISTED
Healthwell Acquisition Corp. I Unit
HWELU
$1K ﹤0.01%
58
– –
2022 Q4
1 quarter
CWBR
6323
DELISTED
CohBar, Inc. Common Stock
CWBR
$1K ﹤0.01%
+445
New +$899
2023 Q1
0 quarters
FFTI
6324
DELISTED
FormulaFolios Tactical Income ETF
FFTI
$1K ﹤0.01%
+48
New +$991
2023 Q1
0 quarters
SURF
6325
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1K ﹤0.01%
1,407
– –
2021 Q1
8 quarters

Similar funds

JP Morgan Chase's Q1 2023 Portfolio in Review

As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
  • JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
  • JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
  • JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
  • JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
  • JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
  • JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.